These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 127927

  • 1. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD.
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract] [Full Text] [Related]

  • 2. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA, Wurtman RJ.
    N Engl J Med; 1975 Aug 14; 293(7):332-8. PubMed ID: 125386
    [No Abstract] [Full Text] [Related]

  • 3. [Neuraminergic conception of extrapyramidal syndromology].
    Levin SL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977 Aug 14; 77(2):293-9. PubMed ID: 139066
    [No Abstract] [Full Text] [Related]

  • 4. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB.
    Farmakol Toksikol; 1973 Aug 14; 26(4):481-9. PubMed ID: 4151298
    [No Abstract] [Full Text] [Related]

  • 5. Involuntary movement disorders.
    Still CN.
    Neurol Clin; 1984 Feb 14; 2(1):71-89. PubMed ID: 6239089
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD.
    Neuropharmacology; 1972 Sep 14; 11(5):601-7. PubMed ID: 4275111
    [No Abstract] [Full Text] [Related]

  • 7. Amine precursors in neurologic disorders and the psychoses.
    Klawans H.
    Res Publ Assoc Res Nerv Ment Dis; 1975 Sep 14; 54():259-76. PubMed ID: 130667
    [No Abstract] [Full Text] [Related]

  • 8. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 9. Network biomarkers for the diagnosis and treatment of movement disorders.
    Poston KL, Eidelberg D.
    Neurobiol Dis; 2009 Aug 15; 35(2):141-7. PubMed ID: 19013242
    [Abstract] [Full Text] [Related]

  • 10. [Abnormal neurotransmission in neurological diseases (author's transl)].
    Toru M.
    Tanpakushitsu Kakusan Koso; 1979 Aug 15; 24(2):150-9. PubMed ID: 35816
    [No Abstract] [Full Text] [Related]

  • 11. [Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)].
    Ando K.
    Tanpakushitsu Kakusan Koso; 1981 Aug 15; 26(11):1772-80. PubMed ID: 6458067
    [No Abstract] [Full Text] [Related]

  • 12. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM, Davis KL, Berger PA.
    J Clin Psychopharmacol; 1982 Oct 15; 2(5):321-8. PubMed ID: 6127351
    [Abstract] [Full Text] [Related]

  • 13. [Neurologic and psychic complications in treatment with neuroleptics].
    Gerlach J.
    Ugeskr Laeger; 1976 Jun 28; 138(27):1650-3. PubMed ID: 951778
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacology of tardive dyskinesias.
    Klawans HL.
    Am J Psychiatry; 1973 Jan 28; 130(1):82-6. PubMed ID: 4264755
    [No Abstract] [Full Text] [Related]

  • 15. [Biochemical aspects of involuntary movements (author's transl)].
    Nakamura S, Kameyama M.
    No To Shinkei; 1981 Dec 28; 33(12):1177-85. PubMed ID: 7034752
    [No Abstract] [Full Text] [Related]

  • 16. Role of manganese in dystonia.
    Barbeau A, Inoué N, Cloutier T.
    Adv Neurol; 1976 Dec 28; 14():339-52. PubMed ID: 821321
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL.
    Dis Nerv Syst; 1976 Apr 28; 37(4):219-24. PubMed ID: 1253676
    [No Abstract] [Full Text] [Related]

  • 18. Neurochemical anatomy of movement disorders.
    Young AB, Penney JB.
    Neurol Clin; 1984 Aug 28; 2(3):417-33. PubMed ID: 6152481
    [Abstract] [Full Text] [Related]

  • 19. [Drug-induced Parkinson's syndrome].
    Degkwitz R.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):882. PubMed ID: 5032182
    [No Abstract] [Full Text] [Related]

  • 20. [Monoamines and choreic syndromes].
    Constantinidis J.
    Rev Neurol (Paris); 1972 Jul 02; 127(1):65-77. PubMed ID: 4272133
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.